National Cancer Institute Smoking Cessation at Lung Examination Trials Brief Report: Baseline Characteristics and Comparison With the U.S. General Population of Lung Cancer Screening–Eligible Patients

National Cancer Institute Smoking Cessation at Lung Examination Trials Brief Report: Baseline Characteristics and Comparison With the U.S. General Population of Lung Cancer Screening–Eligible Patients

Introduction: The National Cancer Institute Smoking Cessation at Lung Examination (SCALE) Collaboration includes eight clinical trials testing smoking cessation interventions delivered with lung cancer screening (LCS). This investigation compared pooled participant baseline demographic and smoking c...

Full description

Bibliographic Details
Main Authors:	Rafael Meza, PhD, Jihyoun Jeon, PhD, MS, Evelyn Jimenez-Mendoza, MS, Yoonseo Mok, MPH, Pianpian Cao, PhD, MPH, Kristie L. Foley, PhD, MS, Caroline Chiles, MD, Jamie S. Ostroff, PhD, Paul M. Cinciripini, PhD, Jennifer Minnix, PhD, Nancy A. Rigotti, MD, Jennifer S. Haas, MD, Kathryn Taylor, PhD, Randi M. Williams, PhD, MPH, Benjamin A. Toll, PhD, Anne M. Joseph, MD, MPH
Format:	Article
Language:	English
Published:	Elsevier 2022-07-01
Series:	JTO Clinical and Research Reports
Subjects:	Smoking cessation Lung cancer screening Clinical trials Trial participant characteristics
Online Access:	http://www.sciencedirect.com/science/article/pii/S2666364322000765

Similar Items

Somatic and Germline BRCA 1 and 2 Mutations in Advanced NSCLC From the SAFIR02-Lung Trial
by: Jordi Remon, MD, et al.
Published: (2020-09-01)

Point-of-Care Technologies for Precision Cardiovascular Care and Clinical Research
by: Kevin R. King, MD, PhD, et al.
Published: (2016-01-01)

Colorectal Cancer Knowledge and Screening Change in African Americans: Implementation Phase Results of the EPICS Cluster RCT
by: Benjamin E. Ansa, MD, PhD, et al.
Published: (2023-12-01)

Efficacy and Safety of Avanafil in Chinese Subjects With Erectile Dysfunction: A Multi-Center, Randomized, Double-Blinded, Placebo-Controlled Phase III Clinical Trial
by: Hui Jiang, MD, PhD, et al.
Published: (2021-06-01)

A phase 3 randomized, multicenter, double-blind study to evaluate the safety of upadacitinib in combination with topical corticosteroids in adolescent and adult patients with moderate-to-severe atopic dermatitis in Japan (Rising Up): An interim 24-week analysisCapsule Summary
by: Norito Katoh, MD, PhD, et al.
Published: (2022-03-01)

Biomarker Testing, Targeted Therapy and Clinical Trial Participation by Race Among Patients With Lung Cancer: A Real-World Medicaid Database Study
by: Debora S. Bruno, MD, MS, et al.
Published: (2024-03-01)

Lung Cancer Care Before and After Medicare Eligibility
by: Marco D. Huesch MBBS, PhD, et al.
Published: (2016-05-01)

Real-World Evidence of Diagnostic Testing for Driver Oncogene Mutations in Lung Cancer in Japan
by: Yasushi Yatabe, MD, PhD, et al.
Published: (2021-03-01)

A Mixed Methods Population Health Approach to Explore Radon-Induced Lung Cancer Risk Perception in Canada
by: S. M. Khan MD, MPH, PhD, et al.
Published: (2021-09-01)

The longer-term effects of access to HIV self-tests on HIV testing frequency in high-risk gay and bisexual men: follow-up data from a randomised controlled trial
by: Ye Zhang, Mph, et al.
Published: (2021-09-01)

Treatment for Patients With Early Stage Adenosquamous Lung Cancer
by: Jiaxi He, MD, PhD, et al.
Published: (2020-06-01)

Optimized Probability Sampling of Study Sites to Improve Generalizability in a Multisite Intervention Trial
by: Jennifer L. Kraschnewski, MD, et al.
Published: (2010-01-01)

Effective Communication About Lung Cancer Screening Without Iatrogenic Stigma: A Brief Report Case Study Using the Lung Cancer Stigma Communications Assessment Tool of LungTalk
by: Lisa Carter-Bawa, PhD, MPH, APRN, ANP-C, FAAN, et al.
Published: (2023-11-01)

Socio-ecological Model as a Framework for Overcoming Barriers and Challenges in Randomized Control Trials in Minority and Underserved Communities
by: Hamisu M. Salihu, MD, PhD, et al.
Published: (2015-03-01)

Efficacy of Adjuvant Chemotherapy With Tegafur-Uracil in Patients With Completely Resected, Node-Negative NSCLC—Real-World Data in the Era of Molecularly Targeted Agents and Immunotherapy
by: Takehito Shukuya, MD, PhD, et al.
Published: (2022-05-01)

Patient Report on the Impact of Coronavirus Disease 2019 and Living With Lung Cancer
by: Tendai M. Chihuri, MD, MPH, et al.
Published: (2023-09-01)

Health Care Resource Use Among Patients with Advanced Non–Small Cell Lung Cancer in Japan, 2017–2019
by: Yasushi Goto, MD, PhD, et al.
Published: (2023-01-01)

Lung Cancer Patient and Caregiver Health Vulnerabilities and Interest in Health Promotion Interventions: An Exploratory Study
by: Chandylen L Nightingale PhD, MPH, et al.
Published: (2019-07-01)

Simulating and Evaluating Local Interventions to Improve Cardiovascular Health
by: Jack Homer, PhD, et al.
Published: (2010-01-01)

Parent/Guardian Experiences With the Healthcare System and Community Supports for Pediatric Asthma Management
by: Laura J Rolke PhD, MPH, et al.
Published: (2022-04-01)

Effects of preventive online mindfulness interventions on stress and mindfulness: A meta-analysis of randomized controlled trials
by: Wasantha P. Jayawardene, MD, PhD, et al.
Published: (2017-03-01)

The Benefits and Harms of Lung Cancer Screening in Individuals With Comorbidities
by: Minal S. Kale, MD, MPH, et al.
Published: (2024-03-01)

Association of Smoking and Khat (Catha edulis Forsk) Use With High Blood Pressure Among Adults in Addis Ababa, Ethiopia, 2006
by: Fikru Tesfaye, MD, MPH, PhD, et al.
Published: (2008-07-01)

One-Year Incidences of Venous Thromboembolism, Bleeding, and Death in Patients With Lung Cancer (Cancer-VTE Subanalysis)
by: Nobuyasu Awano, MD, PhD, et al.
Published: (2022-09-01)

Clinical Relevance of Patient-Derived Organoid of Surgically Resected Lung Cancer as an In Vitro Model for Biomarker and Drug Testing
by: Takamasa Koga, MD, PhD, et al.
Published: (2023-09-01)

Developing and Testing Implementation Strategies to support the Centers for Disease Control and Prevention's Initiative for Falls Risk Management in Outpatient Physical Therapy: A Protocol
by: Jennifer L. Vincenzo, PhD, MPH, PT, et al.
Published: (2023-06-01)

Association Between Genetic Predictors for C-Reactive Protein and Venous Thromboembolism With Severe Adverse Coronavirus Disease 2019 Outcomes
by: Boya Guo, MPH, et al.
Published: (2021-12-01)

State-specific Prevalence and Factors Associated With Current Marijuana, ENDS, and Cigarette use Among US Adults With Asthma
by: Mohammad Ebrahimi Kalan MS, PhD, et al.
Published: (2022-05-01)

Lung sound analysis for predicting recurrent wheezing in preschool children
by: Manabu Miyamoto, MD, et al.
Published: (2024-02-01)

Impact of pleural effusion at an early period after posterior spinal fusion for adolescent idiopathic scoliosis on future pulmonary function and lung volume
by: Masahiro Ozaki, MD, PhD, et al.
Published: (2023-12-01)

Influence of Yoga on Cancer-Related Fatigue and on Mediational Relationships Between Changes in Sleep and Cancer-Related Fatigue: A Nationwide, Multicenter Randomized Controlled Trial of Yoga in Cancer Survivors
by: Po-Ju Lin PhD, MPH, et al.
Published: (2019-06-01)

A Randomized Study of Safety and Efficacy of Two Doses of Ambrisentan to Treat Pulmonary Arterial Hypertension in Pediatric Patients
by: Dunbar Ivy, MD, et al.
Published: (2020-01-01)

Creation of an Integrated Clinical Trial Database and Data Sharing for Conducting New Research by the Japan Lung Cancer Society
by: Yuichi Ozawa, MD, PhD, et al.
Published: (2022-05-01)

A Case of Lung Cancer with Very-Late-Onset Immune Checkpoint Inhibitor-Related MyocarditisNovel Teaching Points
by: Tatsuya Nishikawa, MD, PhD, et al.
Published: (2022-07-01)

“”: A Narrative Study on Women's Expectations and Experiences of Maternity Care in Bangladesh
by: Md Ruhul Kabir PhD Fellow, MPH, MS, et al.
Published: (2023-11-01)

Variations Between Dose-Ventilation and Dose-Perfusion Metrics in Radiation Therapy Planning for Lung Cancer
by: Yujiro Nakajima, MS, et al.
Published: (2020-05-01)

Multicenter, Retrospective Study to Evaluate Necitumumab Plus Cisplatin and Gemcitabine After Immune Checkpoint Inhibitors in Advanced Squamous Cell Lung Cancer in Japan: The NINJA Study
by: Yasunori Murata, MD, PhD, et al.
Published: (2023-12-01)

Japanese Lung Cancer Society Guidelines for Stage IV NSCLC With EGFR Mutations
by: Kiichiro Ninomiya, MD, PhD, et al.
Published: (2021-01-01)

Impact of Postoperative Continuous Renal Replacement Therapy in Lung Transplant Recipients
by: Masato Katahira, MD, et al.
Published: (2020-06-01)

Detection and Management of Geographic Disparities in the TOPCAT Trial
by: Michael R. Bristow, MD, PhD, et al.
Published: (2016-04-01)